No Data
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
Collaboration aims to accelerate the development of personalized therapies and transform patient care through the use of precision medicine TAMPA, Fla. & LOS ANGELES--(BUSINESS WIRE)--May 14, 2024-- M
Earnings Release: Here's Why Analysts Cut Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target To US$26.67
Investors in Fulgent Genetics, Inc. (NASDAQ:FLGT) had a good week, as its shares rose 4.4% to close at US$21.49 following the release of its first-quarter results. It looks like the results wer
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fulgent Genetics (FLGT), Cigna (CI) and PROCEPT BioRobotics (PRCT)
Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Fulgent Genetics Releases Updated Investor Presentation
Silverbat : Buy at dips and hold for 192